What is the Growth Outlook for Drug Screening Market?

Drug Screening Market

According to the MarketsandMarkets, the Global Drug Screening Market size is estimated to grow at a CAGR of 16.8 % by 2026.

Market Definition

Drug screening test basically analyses biological samples including blood, hair and urine; to diagnose the presence of drug abuse or its metabolites in patient’s body.

Download PDF Brochure @    https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=162987773

Top Key Players are covered in this report:

The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).

The report divides the Drug Screening market by application. By region, by type, and by end user. Each segment of the market is examined broadly to deliver trustworthy knowledge for market investments. The Drug Screening research report reveals the current market norms, latest important revolutions of outcomes, and market players. Hence, this research report will help the customers in the global market plan their next future towards the environment of the markets future.

It additionally discusses about the market size and growth parts of different Segments. Studying and analyzing the impact of Coronavirus COVID-19 on the Drug Screening industry, the report gives an in-depth analysis and expert suggestions on how to face the post COIVD-19 period. This market research study presents actionable market insights with which environmental and profitable business approaches can be created.

Request For Report Description @  https://www.marketsandmarkets.com/Market-Reports/drug-alcohol-screening-market-162987773.html

Regional Assessment: Global Drug Screening Market

North America was the largest regional segment of the overall market with a share of 48.2%, followed by Europe. The dominance of the North American market is attributed to factors such as the growing consumption of illicit drugs, the availability of government funding to curb drug abuse, laws supporting drug screening, the growing burden of accidents due to alcohol impairment, and the presence of key players in the region are driving the growth of the drug screening market in this region.

The study categorizes the Drug screening market into the following segments and subsegments:

By Product and Service

  • Drug Screening Product
  • Analytical Instruments
  • Rapid Testing Devices
  • Oral Fluid Testing Devices
  • Consumables
  • Drug Screening Service

By  Sample Type

  • Urine Samples
  • Breath Samples
  • Oral Fluid Samples
  • Hair Samples
  • Other Samples

By End User

  • Drug Testing Laboratories
  • Workplaces
  • Criminal Justice and Law Enforcement Agencies
  • Hospitals
  • Drug Treatment Centers
  • Individual Users
  • Pain Management Centers
  • Schools and Colleges

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World 

What Information does this report contain? 

Historical data coverage: 2017 to 2021; Growth Projections: 2026. 

Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT. 

6-7 year performance forecasts: major segments covering applications, top products and geographies. 

Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=162987773

Share this post:

Related Posts

Comments are closed.